|
|
|
Simple Device Analyzes Cancer Tumor Cells in the Blood With the Potential of Measuring Treatment Response
Watch NBC News anchorman Brian Williams report on the CTC technology with interviews with Daniel A. Haber, MD, PhD
|
|
Massachusetts General Hospital (MGH) investigators have shown that a microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment. A pilot study of the device called the CTC-chip appears in the July 24 New England Journal of Medicine.
Read More | Read All News
|
|
|
A Single Place A
World of Care.
Researchers Identify Cancer Outcome Predictor
A recent study by Rebecca Heist, MD, MPH, and colleagues, published in the Journal of Clinical Oncology, showed that two variations of the angiogenesis gene VEGF were associated with significant survival differences in early stage non-small cell lung cancer. Plans are underway to assess whether these genetic variations may help predict which treatments will be most beneficial.
|
|
Upcoming Events
Friends of the Cancer Center Charity Shopping Event
Nov. 13, 2008
Read More >
All Events >
|
